← ANALYSTS · TIPRANKS
Yatin Suneja · Guggenheim
Hits
57%
244 of 428 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+33.0%
Over a year after the rating, TipRanks’ measure
Our companies rated now
33
Buy / hold / sell: 30 / 3 / 0
Upside of the analyst’s targets
+387.8%
Average over 30 current targets, to the last price
The market’s answer to the ratings
−0.1%
Day-0 move against SPY in the rating’s direction, average over 15 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks Oct 13 07:10 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $100 | +190.2% | +7.0%next day −6.9% | ↗ |
| Oct 5on TipRanks Oct 6 05:45 | LBRXIWMLB Pharmaceuticals, Inc. · $1.2B | Initiated | Buy | $80.00 | +117.7% | −7.1%next day −1.6% · 5 days +3.4% | ↗ |
| Oct 5on TipRanks Oct 6 05:45 | MPLTIWMMapLight Therapeutics, Inc. · $446M | Initiated | Hold | — | — | −6.2%next day +3.9% · 5 days −7.7% | ↗ |
| Oct 5on TipRanks Oct 6 05:21 | NBIXNeurocrine · $13.9B | Initiated | Buy | $207 | +52.5% | 0.0%next day +0.4% · 5 days −2.4% | ↗ |
| Oct 2on TipRanks Oct 5 04:05 | ZURAIWMZura Bio · $423M | Reiterated | Buy | $20.00 | +415.5% | −1.5%next day −5.1% · 5 days −3.8% | ↗ |
| Sep 28on TipRanks 06:40 | KRSAKorsana Biosciences · $1.4B | Initiated | Buy | $70.00 | +116.2% | +0.2%next day +10.5% · 5 days −1.6% | ↗ |
| Sep 22on TipRanks Sep 23 07:10 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $100 | +263.2% | −11.5%next day −6.4% · 5 days −4.4% | ↗ |
| Sep 16on TipRanks Sep 17 03:55 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Initiated | Buy | $100 | +190.2% | +1.8%next day −0.6% · 5 days −8.1% | ↗ |
| Sep 15on TipRanks Sep 16 07:10 | SIONIWMSionna Therapeutics, Inc. · $184M | Reiterated | Hold | — | — | −16.2%next day +2.8% · 5 days −14.9% | ↗ |
| Sep 8on TipRanks Sep 9 07:30 | ROIVRoivant Sciences · $25.0B | Reiterated | Buy | $42.00 → $46.00+9.5% | +37.2% | +19.3%next day +1.3% · 5 days −3.7% | ↗ |
| Sep 2on TipRanks Sep 3 05:35 | ALMSIWMAlumis Inc. · $842M | Downgrade | Hold | — | — | +8.8%next day +8.7% · 5 days −3.4% | ↗ |
| Aug 26on TipRanks Aug 27 07:20 | SYREIWMSpyre Therapeutics · $7.3B | Reiterated | Buy | $130 | +62.7% | −12.8%next day −0.6% · 5 days −6.9% | ↗ |
| Aug 13on TipRanks Aug 14 08:15 | CABAIWMCabaletta Bio · $275M | Reiterated | Buy | $16.00 | +1,034.8% | −5.6%next day +1.7% · 5 days +19.7% | ↗ |
| Aug 13on TipRanks Aug 14 08:15 | ZBIOIWMZenas BioPharma, Inc. · $1.7B | Reiterated | Buy | $55.00 | +121.4% | −7.4%next day +1.3% · 5 days +10.3% | ↗ |
| Aug 11on TipRanks Aug 12 07:10 | ZURAIWMZura Bio · $423M | Reiterated | Buy | $15.00 → $20.00+33.3% | +415.5% | −0.9%next day +3.7% · 5 days +4.2% | ↗ |
| Aug 11on TipRanks Aug 12 07:10 | IMUXImmunic · $104M | Reiterated | Buy | $70.00 | +904.3% | +10.1%next day +2.7% · 5 days +9.6% | ↗ |
| Aug 10on TipRanks Aug 11 07:10 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $200 | +178.0% | +6.4%next day −0.1% · 5 days +7.2% | ↗ |
| Aug 10on TipRanks Aug 11 06:55 | AXSMAxsome Therapeutics · $8.2B | Reiterated | Buy | $260 → $275+5.8% | +75.0% | +3.9%next day −2.0% · 5 days −2.0% | ↗ |
| Aug 7on TipRanks Aug 10 07:35 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $35.00 | +256.4% | −0.6%next day −3.3% · 5 days +16.2% | ↗ |
| Aug 6on TipRanks Aug 7 08:01 | XENEIWMXenon · $3.3B | Reiterated | Buy | $90.00 | +168.7% | +0.5%next day −2.5% · 5 days −1.7% | ↗ |
| Aug 6on TipRanks Aug 7 08:01 | OCSOculis Holding · $486M | Reiterated | Buy | $45.00 | +517.3% | +2.7%next day +1.8% · 5 days +2.3% | ↗ |
| Aug 6on TipRanks Aug 7 08:01 | PRAXIWMPraxis Precision Medicines · $6.9B | Reiterated | Buy | $800 | +230.9% | +16.1%next day −3.1% · 5 days −1.7% | ↗ |
| Aug 6on TipRanks Aug 7 07:50 | AVTXIWMAvalo Therapeutics · $644M | Reiterated | Buy | $50.00 → $48.00−4.0% | +325.9% | −0.6%next day −2.6% · 5 days +2.8% | ↗ |
| Aug 5on TipRanks Aug 6 06:56 | DNTHIWMDianthus Therapeutics · $4.2B | Reiterated | Buy | $200 | +177.4% | +2.1%next day −2.1% · 5 days −0.4% | ↗ |
| Aug 4on TipRanks Aug 5 02:35 | ARGXArgenx Se · $51.7B | Initiated | Buy | $1,185 | +44.7% | −0.2%next day +3.0% · 5 days +2.5% | ↗ |
| Aug 3on TipRanks 09:35 | REGNQQQSPYRegeneron · $82.0B | Reiterated | Buy | $1,000 → $1,030+3.0% | +30.3% | −1.9%next day −1.6% · 5 days +4.4% | ↗ |
| Jul 31on TipRanks 07:18 | PHATIWMPhathom Pharmaceuticals · $607M | Reiterated | Buy | $25.00 → $22.00−12.0% | +217.9% | −3.8%next day +1.2% · 5 days −5.8% | ↗ |
| Jul 31on TipRanks 07:00 | NBIXNeurocrine · $13.9B | Reiterated | Buy | $200 → $222+11.0% | +63.6% | −10.8%next day −1.8% · 5 days −5.5% | ↗ |
| Jul 21on TipRanks Jul 24 05:14 | BIIBSPYBiogen · $34.8B | Assigned | Buy | $260 → $280+7.7% | +20.4% | +0.8%next day −2.6% · 5 days +2.2% | ↗ |
| Jul 17on TipRanks 07:17 | DBVTDBV Technologies SA - American · $719M | Reiterated | Buy | $51.00 | +463.5% | −0.1%next day −0.7% · 5 days −6.7% | ↗ |
| Jul 1on TipRanks Jul 2 04:25 | ABVXAbivax SA Sponsored ADR · $8.6B | Reiterated | Buy | $175 | +98.6% | −0.4%next day +9.3% · 5 days +5.4% | ↗ |
| Jun 24on TipRanks 16:35 | EYPTIWMEyePoint Pharmaceuticals · $271M | Reiterated | Buy | $68.00 | +2,174.2% | −4.9%next day +0.4% · 5 days +0.5% | ↗ |
| May 26on TipRanks 06:50 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $44.00 → $62.00+40.9% | +131.9% | −1.6%next day −1.2% · 5 days −9.8% | ↗ |
| May 7on TipRanks May 8 07:30 | STOKIWMStoke Therapeutics · $1.6B | Reiterated | Buy | $60.00 | +148.2% | −1.2%next day −0.5% · 5 days −6.6% | ↗ |
| May 7on TipRanks May 8 07:30 | NMRAIWMNeumora Therapeutics, Inc. · $80M | Reiterated | Buy | $14.00 | +2,859.8% | −16.4%next day −6.5% · 5 days −0.7% | ↗ |
| Mar 4on TipRanks 07:40 | ANABIWMAnaptysBio · $1.5B | Reiterated | Buy | $140 | +200.4% | +13.9%next day −4.8% · 5 days +8.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗